IRulya Therapeutics Inc.

IRLA· Nasdaq

Since Oct 16, 2025

Transactions: 1
Purchases: 0
Sales: 1
Purchase value: $0.00
Sale value: $173.50K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Benatti LucaDirector

Filed Dec 29, 2025Period of report Dec 26, 20250000912282-25-001469

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleDec 26, 2025	Common Stock^F1	50,000	$3.47	$173.50K	39,179	Direct

Filing footnotes · 1

F1The sale price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.45 to $3.56, inclusive. The reporting person undertakes to provide to Quince Therapeutics, Inc., any security holder of Quince Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.